
Join to View Full Profile
165 Cambridge St Ste 302Boston, MA 02114
Phone+1 617-726-5050
Dr. Cui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2011 - 2015
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2008 - 2011
- Peking Union Medical CollegeClass of 2007
Certifications & Licensure
- MA State Medical License 2011 - 2026
- PA State Medical License 2008 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections Start of enrollment: 2017 Aug 15
Publications & Presentations
PubMed
- The Alpha to Omega of Dialysis Access: Arteriovenous Fistula and Graft (Part 1).Mohammad Ghasemi-Rad, Kelly Trinh, Mohadese Ahmadzade, Kevin Agahi, Xavier Jefferson
Vascular and Endovascular Surgery. 2025-03-24 - The Alpha to Omega of Dialysis Access: Evaluation, Interventions, Innovations (Part 2).Mohammad Ghasemi-Rad, Kelly Trinh, Mohadese Ahmadzade, Kevin Agahi, Xavier Jefferson
Vascular and Endovascular Surgery. 2025-03-15 - Beyond the Veins: Uncovering the History and Advancements of Vascular Access.Alexis M Cahalane, Zubin Irani, Jie Cui
Kidney360. 2023-08-01
Press Mentions
- Coronavirus: Two Strains Are Spreading and 70% Have Worst OneMarch 6th, 2020
- Coronavirus Has Two Strains: L-type More Aggressive and Contagious Than S-type, Says StudyMarch 5th, 2020
- BREAKING NEWS! Coronavirus Has Two Strains and Possible More on the Way: Type S Strains Spread the Disease Without Them Even KnowingMarch 4th, 2020
Grant Support
- Development of drug conjugates of R-spondin peptibodies for the treatment of colorectal cancerWNTRIX, INC.2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: